← Back to headlines
Johnson & Johnson Highlights Positive Caplyta Data for Depression Therapy
Johnson & Johnson is promoting new data supporting Caplyta as an effective add-on therapy for depression.
4 May, 20:56 — 4 May, 20:56
Sources
Showing 1 of 1 sources
